What are the effects of aspirin on risks of vascular events and cancer according to bodyweight and dose?
A systematic review and meta-Analysis of the effects of aspirin on risks of vascular events and cancer according to bodyweight and dose was conducted by Rothwell et al. (2018). The results showed that the risks of vascular events and cancer were significantly lower in individuals taking higher doses of aspirin than in those taking lower doses. Moreover, the risk of cancer was lowest in individuals taking the highest doses of aspirin, while the risk of vascular events was highest in individuals taking the lowest doses. These findings suggest that higher doses of aspirin may be beneficial for reducing the risks of both vascular events and cancer.  